Our ultimate goal is to determine how aberrant immune responses to rubella virus contribute to the clinical and pathological manifestations of the congenital rubella syndrome, progressive rubella panencephalitis, vaccine arthralgia and perhaps rheumatoid arthritis and multiple sclerosis. A prerequisite is the construction of the molecular topography of the antigenic domains of rubella virus which elicit humoral and cell-mediated immune responses. This will provide the required data base to define the predicted alterations in the human immune response which contribute to the diverse complications of rubella. This project will define the minimum domains of rubella virus that are required to induce antibody responses which interrupt virus infectivity, and those amino acid sequences of the structural proteins which are processed and presented by human monocytes to establish cellular immunity. A library of monoclonal antibodies to rubella virus will be expanded and used to define both sequential and conformation- dependant antigen bearing domains residing on the structural polypeptides. These experiments will utilize novel approaches which combine the power of immunoprecipitation, antibody protected partial proteolytic digestion, SDS-PAGE and fast atom bombardment mass spectrometry. In vitro proliferative assays which use polypeptides or their fragments bound to particulate nitrocellulose will define antigenic domains recognized by immune cells. Selected synthetic oligopeptides will confirm the importance of these domains and provide reagents with which to probe critical differences between normal and anomalous responses in rubella related syndromes. The knowledge gained will increase our understanding of normal immune responses to this common human pathogen, provide critical information of use in constructing molecularly engineered vaccines, facilitate the approach of others to this general problem, and provide better insight into aberrant human immune responses and their contribution to viral persistence and virus-induced immunopathology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026943-03
Application #
3141047
Study Section
Experimental Virology Study Section (EVR)
Project Start
1989-06-01
Project End
1994-05-31
Budget Start
1991-06-01
Budget End
1992-05-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Williams, L L; Lew, H M; Davidorf, F H et al. (1994) Altered membrane fatty acids of cultured human retinal pigment epithelium persistently infected with rubella virus may affect secondary cellular function. Arch Virol 134:379-92
McCarthy, M; Lovett, A; Kerman, R H et al. (1993) Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides. J Virol 67:673-81
Lovett, A E; McCarthy, M; Wolinsky, J S (1993) Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptides. J Gen Virol 74 ( Pt 3):445-52
Williams, L L; Lew, H M; Shannon, B T et al. (1993) Phagocytosis of latex beads is defective in cultured human retinal pigment epithelial cells with persistent rubella virus infection. Am J Pathol 142:451-61
Wolinsky, J S; Sukholutsky, E; Moore, W T et al. (1993) An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J Virol 67:961-8
Karounos, D G; Wolinsky, J S; Thomas, J W (1993) Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 150:3080-5
Lovett, A E; Hahn, C S; Rice, C M et al. (1993) Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes. J Virol 67:5849-58
Williams, L L; Wolinsky, J S; Cao, S N et al. (1992) Antibody response to rubella virus antigen and structural proteins in retinitis pigmentosa. J Infect Dis 166:525-30
Wolinsky, J S; McCarthy, M; Allen-Cannady, O et al. (1991) Monoclonal antibody-defined epitope map of expressed rubella virus protein domains. J Virol 65:3986-94
Nath, A; Wolinsky, J S (1990) Antibody response to rubella virus structural proteins in multiple sclerosis. Ann Neurol 27:533-6